CMND
NASDAQ · Pharmaceuticals
Clearmind Medicine Inc
$2.68
-0.29 (-9.76%)
Open$2.94
Previous Close$2.97
Day High$2.95
Day Low$2.62
52W High$524.00
52W Low—
Volume—
Avg Volume4.68M
Market Cap4.56M
P/E Ratio—
EPS$-544.74
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 523.5K | 483.3K | 576.6K |
| Net Income | 68.9K | 73.1K | 95.7K |
| Profit Margin | 13.2% | 15.1% | 16.6% |
| EBITDA | 118.6K | 102.7K | 135.6K |
| Free Cash Flow | 93.6K | 59.2K | 119.0K |
| Rev Growth | +19.2% | +7.8% | +18.0% |
| Debt/Equity | 0.43 | 0.45 | 0.38 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |